MicroTransponder Closes $5.5M Funding
Summary
MicroTransponder Inc., a Dallas, Texas-based medical device development company, closed a $5.5m round of funding.The company intends to use the funds to commercialize its stroke and tinnitus therapy in Europe in 2016 and complete additional clinical studies.Led by Frank McEachern, CEO, MicroTransponder has developed and continue to expand neurostimulation programs to treat various forms of neurological diseases, including post stroke motor rehabilitation and tinnitus.It consists of a small implanted battery and wires that internally connect to the vagus nerve in the neck.During the rehabilitative therapy, the patient receives a small amount of neurostimulation to the vagus nerve to strengthen the neural pathways in the brain.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected